SEP Analytical (Shanghai) Co. Ltd. (301228) — Capital Reinvestment Ratio
SEP Analytical (Shanghai) Co. Ltd. (301228) has a Capital Reinvestment Ratio of 1.47x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥39.86 Million) in capital expenditures (CN¥58.71 Million). See 301228 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SEP Analytical (Shanghai) Co. Ltd. Capital Reinvestment Ratio (2019–2025)
This chart tracks SEP Analytical (Shanghai) Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check SEP Analytical (Shanghai) Co. Ltd. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SEP Analytical (Shanghai) Co. Ltd. (2019–2025)
Year-by-year Capital Reinvestment Ratio for SEP Analytical (Shanghai) Co. Ltd. from 2019 to 2025. For live market cap and broader valuation context, see 301228 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.47x | CN¥39.86 Million | CN¥58.71 Million | ▲ +122.7% |
| 2024 | 0.66x | CN¥24.35 Million | CN¥16.11 Million | ▼ -90.2% |
| 2022 | 6.73x | CN¥7.82 Million | CN¥52.64 Million | ▲ +1929.5% |
| 2021 | 0.33x | CN¥86.53 Million | CN¥28.70 Million | ▼ -82.7% |
| 2020 | 1.92x | CN¥38.75 Million | CN¥74.34 Million | ▼ -41.2% |
| 2019 | 3.26x | CN¥22.49 Million | CN¥73.37 Million | — |